American Journal of Ophthalmology
Volume 149, Issue 3 , Pages 482-487.e2 , March 2010

Acute Endophthalmitis After Cataract Surgery: 250 Consecutive Cases Treated at a Tertiary Referral Center in the Netherlands

  • Benjamin J. Pijl

      Affiliations

    • Department of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  • ,
  • Thomas Theelen

      Affiliations

    • Department of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  • ,
  • Maurits A.D. Tilanus

      Affiliations

    • Department of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  • ,
  • Rob Rentenaar

      Affiliations

    • Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  • ,
  • Niels Crama

      Affiliations

    • Department of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • Corresponding Author InformationInquiries to Niels Crama, MD, Department of Ophthalmology, Radboud University Nijmegen Medical Centre, Internal postal code 400, P.O. Box 9100, 6500 HB Nijmegen, The Netherlands

,Accepted 30 September 2009.

References 

  1. Miller JJ, Scott IU, Flynn HW, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983–987
  2. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–1496
  3. Theelen T, Tilanus MAD. Treatment of acute bacterial endophthalmitis after cataract surgery without vitrectomy. In:  Kirchhof B,  Wond D editor. Vitreo-Retinal Surgery. Berlin, Heidelberg: Springer; 2007;p. 69–83
  4. Kuhn F, Gini G. Ten years afterare findings of the Endophthalmitis Vitrectomy Study still relevant today?. Graefes Arch Clin Exp Ophthalmol. 2005;243:1197–1199
  5. Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122:830–846
  6. Lalwani GA, Flynn HW, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996–2005) (Clinical features, causative organisms, and visual acuity outcomes). Ophthalmology. 2008;115:473–476
  7. Miller JJ, Scott IU, Flynn HW, Smiddy WE, Corey RP, Miller D. Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol. 2004;138:231–236
  8. Sandvig KU, Dannevig L. Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg. 2003;29:1273–1280
  9. Wong TY, Chee SP. The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology. 2004;111:699–705
  10. Kamalarajah S, Silvestri G, Sharma N, et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye. 2004;18:580–587
  11. Wejde G, Montan P, Lundstrom M, Stenevi U, Thorburn W. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999–2001. Acta Ophthalmol Scand. 2005;83:7–10
  12. Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study (Relationship between clinical presentation and microbiologic spectrum). Ophthalmology. 1997;104:261–272
  13. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery (Effect of incision placement and intraocular lens type). J Cataract Refract Surg. 2003;29:20–26
  14. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998;43:193–224
  15. Roth DB, Flynn HW. Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy. Surv Ophthalmol. 1997;41:395–401
  16. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1–17
  17. Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111–124
  18. Kuhn F, Giampaolo G. Complete and early vitrectomy for endophthalmitis (CEV) as today's alternative to the Endophthalmitis Vitrectomy Study. In:  Kirchhof B,  Wond D editor. Vitreo-Retinal Surgery. Berlin, Heidelberg: Springer; 2009;p. 53–68
  19. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol. 1999;83:1050–1055
  20. Gan IM, Ugahary LC, van Dissel JT, et al. Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefes Arch Clin Exp Ophthalmol. 2005;243:1200–1205
  21. Shah GK, Stein JD, Sharma S, et al. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology. 2000;107:486–489
  22. Gregory M, Callegan MC, Gilmore MS. Role of bacterial and host factors in infectious endophthalmitis. Chem Immunol Allergy. 2007;92:266–275

PII: S0002-9394(09)00734-X

doi: 10.1016/j.ajo.2009.09.021

American Journal of Ophthalmology
Volume 149, Issue 3 , Pages 482-487.e2 , March 2010